By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MabCure, Inc. 

3702 South Virginia Street
Suite G12-401
Reno  Nevada  89502  U.S.A.
Phone: 601-432-7447 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
MabCure, Inc. Announces Agreement with the City University of New York Center for Advanced Technology to Validate and Evaluate its Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagents 3/19/2012 8:10:17 AM
MabCure, Inc. Announces Completion of Its Ovarian Cancer Diagnostic Study in Thailand 12/16/2011 6:59:34 AM
MabCure, Inc. Receives U$500,000.00 Licensing Fee as Well as 12.5% Ongoing Royalty for Its Prostate Cancer Diagnostic Technology 11/23/2011 9:22:32 AM
MabCure, Inc. Study Results on a New Ovarian Cancer Diagnostic Blood Test Being Presented at the Annual Meeting of the Society of Gynecological Oncologists 3/8/2011 8:27:58 AM
MabCure, Inc., Corporate Update 3/1/2011 11:15:56 AM
MabCure, Inc. Secures $10 Million Funding Commitment from an Institutional Investor Managed by Roswell Capital Partners 1/20/2011 6:29:43 AM
MabCure, Inc. Welcomes Dr. Charles T. Tackney as New Chief Scientific Officer 12/6/2010 11:40:36 AM
MabCure, Inc. Completes 23.1 Million Australian Dollar Private Placement 12/6/2010 7:32:03 AM
MabCure, Inc. Generates Tumor Specific Antibodies against Prostate Cancer Which Could Lead to a Blood/Urine Diagnostic Test for Prostate Cancer 11/8/2010 12:07:54 PM
MabCure, Inc. Files Provisional Patent in the U.S. for Ovarian Cancer Antibodies 8/3/2010 9:29:27 AM
123
//-->